Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arformoterol Efficacy and Safety in COPD
NCT00685841Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Feb 2002
- Primary completion
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arformoterol in chronic obstructive pulmonary disease (COPD), sponsored by Sumitomo Pharma America. Started Feb 2002; status: completed.
02
Drugs
arformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00685841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00685841.